• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Clinical Pharmacology and Therapeutics of Hypertension

Clinical Pharmacology and Therapeutics of Hypertension

Handbook of Hypertension Series

9780444517579
614.88 zł
522.65 zł Save 92.23 zł Tax included
Lowest price within 30 days before promotion: 522.65 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
This volume reviews comprehensively the present understanding of the clinical pharmacology and therapeutics of currently available antihypertensive agents. As fewer new molecules are entering development it becomes increasingly important to utilise existing drugs in a way that exploits their full potential through a greater understanding of their molecular biology and pharmacogenomics.
Product Details
Elsevier
31346
9780444517579
9780444517579

Data sheet

Publication date
2008
Issue number
1
Cover
hard cover
Pages count
608
Dimensions (mm)
246 x 189
Weight (g)
1330
  • Section I: General considerations:

    Classification of antihypertensive drugs and pharmacological considerations. Interaction of antihypertensive drugs with mechanisms of blood pressure regulation. Antihypertensive drugs: pharmacokinetics, pharmacodynamics, metabolism, side effects and drug interactions. Antihypertensive drugs: hemodynamic effects.

    Section II: Diuretics:

    Thiazides and loop diuretics. Aldosterone antagonists

    Section III: Centrally acting drugs:

    Methyldopa and imidazolone agonists.

    Section IV: Vasodilator drugs:

    Alpha-blocking drugs. Calcium channel blockers. Potent vasodilators.

    Section V: Beta-blocking agents:

    Beta-adrenoceptor blocking drugs.

    Section VI: Drugs acting on the renin-angiotensin system:

    Angiotensin converting enzyme inhibitors. Angiotensin receptor blockers. Vasopeptidase inhibitors.

    Section VII: Future prospects:

    Novel agents in development.

    Section VIII: Clinical trials:

    The evidence-base for treatment of hypertension.

    Section IX: Therapeutic strategies:

    Combination therapy. Sequential monotherapy.

    Section X: Special patient groups:

    Pregnancy. The elderly. Hypertension and diabetes. Ethnic considerations in hypertension.
Comments (0)